Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
27,915,073
-
Share change
-
+2,131,299
-
Total reported value
-
$105,520,868
-
Price per share
-
$3.78
-
Number of holders
-
67
-
Value change
-
+$8,133,108
-
Number of buys
-
39
-
Number of sells
-
25
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q2 2020
As of 30 Jun 2020,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,915,073 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Ikarian Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Hudson Bay Capital Management LP, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.